Literature DB >> 9732910

Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease.

C S Philipp1, L A Cisar, P Saidi, J B Kostis.   

Abstract

This study demonstrates that niacin supplementation decreases plasma fibrinogen and low-density lipoprotein cholesterol in subjects with peripheral vascular disease randomized to receive niacin, warfarin, antioxidants, or placebo. Changes in fibrinogen levels are highly correlated with changes in low-density lipoprotein cholesterol (r = 0.61; p < 0.009) in subjects taking niacin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732910     DOI: 10.1016/s0002-9149(98)00393-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 2.  The role of nutrition and body composition in peripheral arterial disease.

Authors:  Diana P Brostow; Alan T Hirsch; Tracie C Collins; Mindy S Kurzer
Journal:  Nat Rev Cardiol       Date:  2012-08-28       Impact factor: 32.419

Review 3.  Lipid-lowering for peripheral arterial disease of the lower limb.

Authors:  P P Aung; H G Maxwell; R G Jepson; J F Price; G C Leng
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

4.  Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis.

Authors:  Menglei Li; Yang Wu; Jiwang Zhang; Lijun Huang; Xianlan Wu; Yongqiang Yuan
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.